Tavapadon 0.25mg

( DrugBank: Tavapadon / KEGG DRUG: Tavapadon )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	14

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 10 of 14 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-002949-38-BG (EUCTR)	13/01/2021	21/12/2020	A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, PARALLEL GROUP, 27 WEEK TRIAL TO EVALUATE T ...	A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, PARALLEL GROUP, 27 WEEK TRIAL TO EVALUATE T ...	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease MedDRA version: 20.0;Level: ...	Product Name: Tavapadon 0.25mg Product Code: CVL-751 INN or Proposed INN: TAVAPADON Other descriptive n ...	Cerevel Therapeutics, LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	522	Phase 3	United States;Czechia;Spain;Ukraine;Israel;Italy;France;Czech Republic;Hungary;Canada;Poland;Austral ...
2	EUCTR2019-002951-40-BG (EUCTR)	11/01/2021	05/01/2021	A clinical trial which runs in multiple countries and aims to analyse how efficient, safe and tolera ...	A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Flexible-Dose, 27-Week Tria ...	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease with Motor Fluctuations MedD ...	Product Name: Tavapadon 5mg Product Code: CVL-751 INN or Proposed INN: TAVAPADON Other descriptive name ...	Cerevel Therapeutics, LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	368	Phase 3	Serbia;United States;Czechia;Spain;Ukraine;Israel;Italy;France;Czech Republic;Hungary;Canada;Poland; ...
3	EUCTR2019-002952-17-HU (EUCTR)	30/12/2020	19/10/2020	A clinical trial which runs in multiple countries and aims to evaluate the long-term safety and tole ...	58-Week Open-label Trial of Tavapadon in Parkinson’s Disease (TEMPO-4 Trial) - TEMPO-4	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease MedDRA version: 20.0;Level: ...	Product Name: Tavapadon 5mg Product Code: CVL-751 INN or Proposed INN: TAVAPADON Other descriptive name ...	Cerevel Therapeutics, LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	854	Phase 3	United States;Serbia;Spain;Ukraine;Israel;Italy;France;Hungary;Czech Republic;Canada;Poland;Australi ...
4	EUCTR2019-002951-40-IT (EUCTR)	30/10/2020	21/01/2021	A clinical trial which runs in multiple countries and aims to analyse how efficient, safe and tolera ...	A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Flexible-Dose, 27-Week Tria ...	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease with Motor Fluctuations MedD ...	Product Name: Tavapadon 5mg Product Code: [CVL-751] INN or Proposed INN: Tavapadon Product Name: Tavapa ...	Cerevel Therapeutics LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	368	Phase 3	Serbia;United States;Czechia;Spain;Ukraine;Israel;Italy;France;Czech Republic;Hungary;Canada;Poland; ...
5	EUCTR2019-002949-38-DE (EUCTR)	07/09/2020	21/01/2020	A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, PARALLEL GROUP, 27 WEEK TRIAL TO EVALUATE T ...	A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, PARALLEL GROUP, 27 WEEK TRIAL TO EVALUATE T ...	Patients (18 to 60 years age) who have diagnosis of Parkinson's Disease;Therapeutic area: Diseases [ ...	Product Name: Tavapadon 0.25mg Product Code: CVL-751 INN or Proposed INN: TAVAPADON Other descriptive n ...	Cerevel Therapeutics, LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	552	Phase 3	Serbia;United States;Czechia;Spain;Ukraine;Israel;Italy;France;Czech Republic;Hungary;Canada;Poland; ...
6	EUCTR2019-002951-40-DE (EUCTR)	29/07/2020	12/02/2020	A clinical trial which runs in multiple countries and aims to analyse how efficient, safe and tolera ...	A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Flexible-Dose, 27-Week Tria ...	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease with Motor Fluctuations MedD ...	Product Name: Tavapadon 5mg Product Code: CVL-751 INN or Proposed INN: TAVAPADON Other descriptive name ...	Cerevel Therapeutics, LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	368	Phase 3	Serbia;United States;Czechia;Spain;Ukraine;Israel;Italy;France;Czech Republic;Hungary;Canada;Poland; ...
7	EUCTR2019-002951-40-HU (EUCTR)	02/07/2020	29/04/2020	A clinical trial which runs in multiple countries and aims to analyse how efficient, safe and tolera ...	A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Flexible-Dose, 27-Week Tria ...	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease with Motor Fluctuations MedD ...	Product Name: Tavapadon 5mg Product Code: CVL-751 INN or Proposed INN: TAVAPADON Other descriptive name ...	Cerevel Therapeutics, LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	368	Phase 3	United States;Serbia;Spain;Ukraine;Israel;Italy;France;Hungary;Czech Republic;Canada;Poland;Australi ...
8	EUCTR2019-002949-38-IT (EUCTR)	21/05/2020	21/01/2021	A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, PARALLEL GROUP, 27 WEEK TRIAL TO EVALUATE T ...	A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, PARALLEL GROUP, 27 WEEK TRIAL TO EVALUATE T ...	Patients (18 to 60 years age) who have diagnosis of Parkinson's Disease MedDRA version: 20.0;Level: ...	Product Name: Tavapadon 5mg Product Code: [CVL-751] INN or Proposed INN: TAVAPADON Product Name: Tavapa ...	Cerevel Therapeutics LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	522	Phase 3	Serbia;United States;Czechia;Spain;Ukraine;Israel;Italy;France;Czech Republic;Hungary;Canada;Poland; ...
9	EUCTR2019-002950-22-IT (EUCTR)	21/05/2020	15/06/2021	A clinical trial which runs in multiple countries and aims to analyse how efficient, safe and tolera ...	A Phase 3, Double-Blind, Randomized, Placebo Controlled, Parallel Group, Flexible-Dose, 27 Week Tria ...	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease MedDRA version: 20.0;Level: ...	Product Name: Tavapadon 5mg Product Code: [CVL-751] INN or Proposed INN: Tavapadon Other descriptive na ...	Cerevel Therapeutics LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	296	Phase 3	Serbia;United States;Czechia;Spain;Ukraine;Israel;Italy;France;Hungary;Canada;Poland;Australia;Bulga ...
10	EUCTR2019-002949-38-PL (EUCTR)	13/05/2020	20/02/2020	A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, PARALLEL GROUP, 27 WEEK TRIAL TO EVALUATE T ...	A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, PARALLEL GROUP, 27 WEEK TRIAL TO EVALUATE T ...	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease MedDRA version: 20.0;Level: ...	Product Name: Tavapadon 0.25mg Product Code: CVL-751 INN or Proposed INN: TAVAPADON Other descriptive n ...	Cerevel Therapeutics, LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	522	Phase 3	Serbia;United States;Spain;Ukraine;Israel;Italy;France;Czech Republic;Hungary;Canada;Poland;Australi ...

First Previous1 2Next Last